Changes in Antibody Seroprevalence of Seven High-Risk HPV Types between Nationwide Surveillance Studies from 1995–96 and 2006–07 in The Netherlands

Sexually Transmitted Diseases Among Users of Erectile Dysfunction Drugs: Analysis of Claims Data

(2013) Anupam B. Jena   ANNALS OF INTERNAL MEDICINE

Current concepts on human papillomavirus infections in children

(2010) STINA SYRJÄNEN   APMIS

Seroprevalence of Antibodies against Human Papillomavirus (HPV) Types 16 and 18 in Four Continents: the International Agency for Research on Cancer HPV Prevalence Surveys

(2010) S. Vaccarella et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

(2010) Ni Li et al.   INTERNATIONAL JOURNAL OF CANCER

Seroprevalence and Determinants of Eight High-Risk Human Papillomavirus Types in Homosexual Men, Heterosexual Men, and Women: A Population-Based Study in Amsterdam

(2010) Marlies Heiligenberg et al.   SEXUALLY TRANSMITTED DISEASES

Age-specific HPV seroprevalence among young females in The Netherlands

(2010) M. Kramer et al.   SEXUALLY TRANSMITTED INFECTIONS

Prevalence and stability of antibodies to 37 human papillomavirus types — A population-based longitudinal study

(2010) Annika Antonsson et al.   VIROLOGY

HPV - immune response to infection and vaccination

(2010) Margaret Stanley   Infectious Agents and Cancer

Time trends of human papillomavirus type distribution in Italian women with cervical intraepithelial neoplasia (CIN)

(2009) Barbara Dal Bello et al.   GYNECOLOGIC ONCOLOGY

Temporal trends over 3 decades and intrafamilial clustering of HPV types in Swedish patients with cervical cancerin situ

(2009) Emma L. Ivansson et al.   INTERNATIONAL JOURNAL OF CANCER

Comparison of Liquid-Based Cytology With Conventional Cytology for Detection of Cervical Cancer Precursors

(2009) Albertus G. Siebers et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Absolute risk reductions, relative risks, relative risk reductions, and numbers needed to treat can be obtained from a logistic regression model

(2009) Peter C. Austin   JOURNAL OF CLINICAL EPIDEMIOLOGY

Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004

(2009) Lauri E. Markowitz et al.   JOURNAL OF INFECTIOUS DISEASES

Clinician's guide to human papillomavirus immunology: knowns and unknowns

(2009) Mark H Einstein et al.   LANCET INFECTIOUS DISEASES

Population Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in Men, Women, and Children in Australia

(2008) Anthony T. Newall et al.   CLINICAL INFECTIOUS DISEASES

Trends in sexually transmitted infections (other than HIV) in older people: analysis of data from an enhanced surveillance system

(2008) A T Bodley-Tickell et al.   SEXUALLY TRANSMITTED INFECTIONS